Ratings Proto Labs, Inc.

Equities

PRLB

US7437131094

Real-time Estimate Cboe BZX 14:00:39 2024-04-29 EDT 5-day change 1st Jan Change
31.5 USD +0.40% Intraday chart for Proto Labs, Inc. -0.88% -19.20%

Summary

  • The company presents an interesting fundamental situation from a short-term investment perspective.

Strengths

  • The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
  • For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
  • For the past twelve months, EPS forecast has been revised upwards.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
  • The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
  • Over the past twelve months, analysts' opinions have been strongly revised upwards.
  • Considering the small differences between the analysts' various estimates, the group's business visibility is good.

Weaknesses

  • With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
  • The company does not generate enough profits, which is an alarming weak point.
  • The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 32.45 times its estimated earnings per share for the ongoing year.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Industrial Machinery & Equipment

1st Jan change Capi. Investor Rating ESG Refinitiv
-19.20% 802M
C
+12.53% 82.35B
A-
+20.26% 71.09B
B
+20.70% 37.73B
B-
+15.69% 32.01B
A
+9.19% 27.2B
B-
+4.71% 26.74B
C+
+3.90% 26B
B+
+13.27% 25.5B
B+
+16.86% 24.76B
B
Investor Rating
Trading Rating
ESG Refinitiv

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
-

Valuation

P/E ratio
EV / Sales
-
Price to Book
-
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Environment

Emissions
Innovation
Use of resources

Social

Social commitment
Human Rights
Product liability
Human Resources

Governance

CSR Strategy
Management
Shareholders

Controversy

Controversy

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. PRLB Stock
  4. Ratings Proto Labs, Inc.